+1 347 708 0418
PARP (Poly ADP-ribose Polymerase) Inhibitors market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global PARP (Poly ADP-ribose Polymerase) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Olaparib
Talazoparib
Segment by Application
Ovarian Cancer
Breast Cancer
Other
By Company
AbbVie
Pfizer
AstraZeneca
GlaxoSmithKline
Clovis Oncology
Everest Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Olaparib
1.2.3 Talazoparib
1.3 Market by Application
1.3.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Perspective (2017-2028)
2.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Growth Trends by Region
2.2.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Region (2017-2022)
2.2.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Region (2023-2028)
2.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Dynamics
2.3.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Trends
2.3.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Drivers
2.3.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Challenges
2.3.4 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Revenue
3.1.1 Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Revenue (2017-2022)
3.1.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Players (2017-2022)
3.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue
3.4 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Ratio
3.4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue in 2021
3.5 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players Head office and Area Served
3.6 Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Product Solution and Service
3.7 Date of Enter into PARP (Poly ADP-ribose Polymerase) Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PARP (Poly ADP-ribose Polymerase) Inhibitors Breakdown Data by Type
4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Type (2017-2022)
4.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Type (2023-2028)
5 PARP (Poly ADP-ribose Polymerase) Inhibitors Breakdown Data by Application
5.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Application (2017-2022)
5.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2017-2028)
6.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type
6.2.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022)
6.2.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028)
6.2.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2017-2028)
6.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application
6.3.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022)
6.3.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028)
6.3.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2017-2028)
6.4 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country
6.4.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022)
6.4.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2017-2028)
7.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type
7.2.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022)
7.2.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028)
7.2.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2017-2028)
7.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application
7.3.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022)
7.3.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028)
7.3.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2017-2028)
7.4 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country
7.4.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022)
7.4.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2017-2028)
8.2 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type
8.2.1 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022)
8.2.2 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028)
8.2.3 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2017-2028)
8.3 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application
8.3.1 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022)
8.3.2 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028)
8.3.3 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2017-2028)
8.4 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region
8.4.1 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2017-2022)
8.4.2 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2017-2028)
9.2 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type
9.2.1 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022)
9.2.2 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028)
9.2.3 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2017-2028)
9.3 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application
9.3.1 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022)
9.3.2 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028)
9.3.3 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2017-2028)
9.4 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country
9.4.1 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022)
9.4.2 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2017-2028)
10.2 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type
10.2.1 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022)
10.2.2 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028)
10.2.3 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2017-2028)
10.3 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application
10.3.1 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022)
10.3.2 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028)
10.3.3 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2017-2028)
10.4 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country
10.4.1 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022)
10.4.2 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.1.4 AbbVie Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
11.1.5 AbbVie Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.2.4 Pfizer Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.3.4 AstraZeneca Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
11.3.5 AstraZeneca Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.4.4 GlaxoSmithKline Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Developments
11.5 Clovis Oncology
11.5.1 Clovis Oncology Company Details
11.5.2 Clovis Oncology Business Overview
11.5.3 Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.5.4 Clovis Oncology Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
11.5.5 Clovis Oncology Recent Developments
11.6 Everest Pharmaceuticals
11.6.1 Everest Pharmaceuticals Company Details
11.6.2 Everest Pharmaceuticals Business Overview
11.6.3 Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.6.4 Everest Pharmaceuticals Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
11.6.5 Everest Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Olaparib
Table 3. Key Players of Talazoparib
Table 4. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region (2017-2022)
Table 8. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region (2023-2028)
Table 10. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Trends
Table 11. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Drivers
Table 12. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Challenges
Table 13. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Restraints
Table 14. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Share by Players (2017-2022)
Table 16. Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors as of 2021)
Table 17. Ranking of Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Product Solution and Service
Table 21. Date of Enter into PARP (Poly ADP-ribose Polymerase) Inhibitors Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2017-2022)
Table 25. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2023-2028)
Table 27. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Share by Application (2017-2022)
Table 29. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Share by Application (2023-2028)
Table 31. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028) & (US$ Million)
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 64. AbbVie Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)
Table 65. AbbVie Recent Developments
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 69. Pfizer Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)
Table 70. Pfizer Recent Developments
Table 71. AstraZeneca Company Details
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 74. AstraZeneca Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)
Table 75. AstraZeneca Recent Developments
Table 76. GlaxoSmithKline Company Details
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 79. GlaxoSmithKline Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)
Table 80. GlaxoSmithKline Recent Developments
Table 81. Clovis Oncology Company Details
Table 82. Clovis Oncology Business Overview
Table 83. Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 84. Clovis Oncology Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)
Table 85. Clovis Oncology Recent Developments
Table 86. Everest Pharmaceuticals Company Details
Table 87. Everest Pharmaceuticals Business Overview
Table 88. Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 89. Everest Pharmaceuticals Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)
Table 90. Everest Pharmaceuticals Recent Developments
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type: 2021 VS 2028
Figure 2. Olaparib Features
Figure 3. Talazoparib Features
Figure 4. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application: 2021 VS 2028
Figure 5. Ovarian Cancer Case Studies
Figure 6. Breast Cancer Case Studies
Figure 7. Other Case Studies
Figure 8. PARP (Poly ADP-ribose Polymerase) Inhibitors Report Years Considered
Figure 9. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region: 2021 VS 2028
Figure 12. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Players in 2021
Figure 13. Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue in 2021
Figure 15. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Type (2017-2028)
Figure 17. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Application (2017-2028)
Figure 18. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Country (2017-2028)
Figure 19. United States PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Type (2017-2028)
Figure 23. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Application (2017-2028)
Figure 24. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Country (2017-2028)
Figure 25. Germany PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Region (2017-2028)
Figure 35. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Type (2017-2028)
Figure 43. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Application (2017-2028)
Figure 44. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Country (2017-2028)
Figure 45. Mexico PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Country (2017-2028)
Figure 51. Turkey PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. AbbVie Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
Figure 55. Pfizer Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
Figure 56. AstraZeneca Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
Figure 57. GlaxoSmithKline Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
Figure 58. Clovis Oncology Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
Figure 59. Everest Pharmaceuticals Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Buy
